Custom-designed proteins as novel therapeutic tools? The case of arrestins

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Gurevich, Vsevolod V ^a   Gurevich, Eugenia V ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CHEMOKINE RECEPTOR CXCR4; CLATHRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PHOSPHODIESTERASE; PROTEIN JNK3; RETINA S ANTIGEN; RHODOPSIN KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR; RHODOPSIN;

BINDING SITE; CELL PROLIFERATION; CELL SURVIVAL; DISEASE ASSOCIATION; GAIN OF FUNCTION MUTATION; GENE THERAPY; HUMAN; INTERNALIZATION; LOSS OF FUNCTION MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; RETINA ROD; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; GENETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; MUTATION; PHOSPHORYLATION; PROTEIN BINDING;

ANIMALS; ARRESTIN; G-PROTEIN-COUPLED RECEPTOR KINASE 1; GENE THERAPY; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; RHODOPSIN;

EID: 77955487306     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399410001444     Document Type: Review

References (163)

1. Bockaert, J. and Pin, J.P. (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO Journal 18, 1723-1729 (Pubitemid 29158516)
2. Rompler, H. et al. (2007) G protein-coupled time travel: evolutionary aspects of GPCR research. Molecular Interventions 7, 17-25 (Pubitemid 46364321)
3. Fredriksson, R. et al. (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology 63, 1256-1272 (Pubitemid 36627220)
4. Rosenbaum, D.M., Rasmussen, S.G. and Kobilka, B.K. (2009) The structure and function of G-protein-coupled receptors. Nature 459, 356-363
5. Hofmann, K.P. et al. (2009) A G protein-coupled receptor at work: the rhodopsin model. Trends in Biochemical Sciences 34, 540-552
6. Hubbell, W.L. et al. (2003) Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Advances in Protein Chemistry 63, 243-290 (Pubitemid 36268430)
7. Scheerer, P. et al. (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455, 497-502
8. Burns, M.E. and Pugh, E.N.J. (2009) RGS9 concentration matters in rod phototransduction. Biophysical Journal 97, 1538-1547
9. Gurevich, V.V. and Gurevich, E.V. (2006) The structural basis of arrestin-mediated regulation of G protein-coupled receptors. Pharmacology &Therapeutics 110, 465-502
10. Krupnick, J.G., Gurevich, V.V. and Benovic, J.L. (1997) Mechanism of quenching of phototransduction: binding competition between arrestin and transducin for phosphorhodopsin. Journal of Biological Chemistry 272, 18125-18131 (Pubitemid 27306397)
11. Goodman, O.B. et al. (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383, 447-450 (Pubitemid 26330835)
12. Laporte, S.A. et al. (2000) The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. Journal of Biological Chemistry 275, 23120-23126 (Pubitemid 30646204)
13. DeWire, S.M. et al. (2007) Beta-arrestins and cell signaling. Annual Review of Physiology 69, 483-510
14. Kendall, R.T. and Luttrell, L.M. (2009) Diversity in arrestin function. Cellular and Molecular Life Sciences 66, 2953-2973
15. Gurevich, V.V. and Gurevich, E.V. (2008) Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms. Molecular Pharmacology 74, 312-316
16. Tobin, A.B., Butcher, A.J. and Kong, K.C. (2008) Location, location, location. . .site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends in Pharmacological Sciences 29, 413-420
17. Kobilka, B.K. and Deupi, X. (2007) Conformational complexity of G-protein-coupled receptors. Trends in Pharmacological Sciences 28, 397-406 (Pubitemid 47087966)
18. Kenakin, T. (2007) Functional selectivity through protean and biased agonism: who steers the ship? Molecular Pharmacology 72, 1393-1401
19. Drake, M.T. et al. (2008) beta-arrestin-biased agonism at the beta2-adrenergic receptor. Journal of Biological Chemistry 283, 5669-5676
20. Schöneberg, T. et al. (2004) Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacology & Therapeutics 104, 173-206 (Pubitemid 39531926)
21. Barak, L.S. et al. (2001) Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proceedings of the National Academy of Sciences of the United States of America 98, 93-98 (Pubitemid 32095869)
22. Rim, J. and Oprian, D.D. (1995) Constitutive activation of opsin: interaction of mutants with rhodopsin kinase and arrestin. Biochemistry 34, 11938-11945
23. Rao, V.R., Cohen, G.B. and Oprian, D.D. (1994) Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639-642 (Pubitemid 24067704)
24. Apfelstedt-Sylla, E. et al. (1993) Ocular findings in a family with autosomal dominant retinitis pigmentosa and a frameshift mutation altering the carboxyl terminal sequence of rhodopsin. British Journal of Ophthalmology 77, 495-501 (Pubitemid 23236725)
25. Kim, R.Y. et al. (1993) Dominant retinitis pigmentosa associated with two rhodopsin gene mutations. Leu-40-Arg and an insertion disrupting the 5′-splice junction of exon 5. Archives of Ophthalmology 111, 1518-1524 (Pubitemid 23331987)
26. Restagno, G. et al. (1993) A large deletion at the 3′end of the rhodopsin gene in an Italian family with a diffuse form of autosomal dominant retinitis pigmentosa. Human Molecular Genetics 2, 207-208 (Pubitemid 23075663)
27. Cideciyan, A.V. et al. (1998) Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proceedings of the National Academy of Sciences of the United States of America 95, 328-333 (Pubitemid 28103953)
28. Fuchs, S. et al. (1995) A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nature Genetics 10, 360-362
29. Xu, J. et al. (1997) Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature 389, 505-509 (Pubitemid 27435327)
30. Chen, J. et al. (1995) Mechanisms of rhodopsin inactivation in vivo as revealed by a COOsteopathic Hospitals-terminal truncation mutant. Science 267, 374-377
31. Chen, C.K. et al. (1999) Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proceedings of the National Academy of Sciences of the United States of America 96, 3718-3722
32. Mendez, A. et al. (2000) Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron 28, 153-164
33. Allen, L.F. et al. (1991) G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America 88, 11354-11358 (Pubitemid 21916039)
34. Gutkind, J.S. et al. (1991) Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proceedings of the National Academy of Sciences of the United States of America 88, 4703-4707
35. Julius, D. et al. (1989) Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244, 1057-1062 (Pubitemid 19152293)
36. Young, D. et al. (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45, 711-719 (Pubitemid 16063134)
37. Young, D. et al. (1988) Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proceedings of the National Academy of Sciences of the United States of America 85, 5339-5342
38. Jackson, T.R. et al. (1988) Themas oncogene encodes an angiotensin receptor. Nature 335, 437-440
39. Guigoni, C. et al. (2005) Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders 11, S25-29 (Pubitemid 40693574)
40. Kuhn, H., Hall, S.W. and Wilden, U. (1984) Light-induced binding of 48-kDa protein to photoreceptor membranes is highly enhanced by phosphorylation of rhodopsin. FEBS Letters 176, 473-478 (Pubitemid 15208287)
41. Pfister, C. et al. (1985) Retinal S antigen identified as the 48K protein regulating light-dependent phosphodiesterase in rods. Science 228, 891-893 (Pubitemid 15021447)
42. Lohse, M.J. et al. (1990) beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 248, 1547-1550
43. Attramadal, H. et al. (1992) Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. Journal of Biological Chemistry 267, 17882-17890
44. Sterne-Marr, R. et al. (1993) Polypeptide variants of beta-arrestin and arrestin3. Journal of Biological Chemistry 268, 15640-15648
45. Craft, C.M., Whitmore, D.H. and Wiechmann, A.F. (1994) Cone arrestin identified by targeting expression of a functional family. Journal of Biological Chemistry 269, 4613-4619 (Pubitemid 24237833)
46. Murakami, A. et al. (1993) X-arrestin: a new retinal arrestin mapping to the X chromosome. FEBS Letters 334, 203-209
47. Lohse, M.J. et al. (1992) Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. Journal of Biological Chemistry 267, 8558-8564
48. Carman, C.V. and Benovic, J.L. (1998) G-protein-coupled receptors: turn-ons and turn-offs. Current Opinion in Neurobiology 8, 335-344 (Pubitemid 28288568)
49. Gurevich, V.V. and Benovic, J.L. (1992) Cell-free expression of visual arrestin. Truncation mutagenesis identifies multiple domains involved in rhodopsin interaction. Journal of Biological Chemistry 267, 21919-21923
50. Li, J. et al. (2004) Structure of bovine rhodopsin in a trigonal crystal form. Journal of Molecular Biology 343, 1409-1438 (Pubitemid 39387834)
51. Gurevich, V.V. and Benovic, J.L. (1993) Visual arrestin interaction with rhodopsin: Sequential multisite binding ensures strict selectivity towards light-activated phosphorylated rhodopsin. Journal of Biological Chemistry 268, 11628-11638 (Pubitemid 23168111)
52. Gurevich, V.V. and Gurevich, E.V. (2004) The molecular acrobatics of arrestin activation. Trends in Pharmacological Sciences 25, 59-112
53. Gurevich, V.V. and Benovic, J.L. (1995) Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recignition region of arrestin. Journal of Biological Chemistry 270, 6010-6016
54. Gurevich, V.V. and Benovic, J.L. (1997) Mechanism of phosphorylation- recognition by visual arrestin and the transition of arrestin into a high affinity binding state. Molecular Pharmacology 51, 161-169 (Pubitemid 27049558)
55. Hirsch, J.A. et al. (1999) The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97, 257-269
56. Han, M. et al. (2001) Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane translocation. Structure 9, 869-880 (Pubitemid 32913504)
57. Milano, S.K. et al. (2002) Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 41, 3321-3328 (Pubitemid 34214030)
58. Sutton, R.B. et al. (2005) Crystal structure of cone arrestin at 2.3Å: evolution of receptor specificity. Journal of Molecular Biology 354, 1069-1080 (Pubitemid 41698916)
59. Vishnivetskiy, S.A. et al. (1999) How does arrestin respond to the phosphorylated state of rhodopsin? Journal of Biological Chemistry 274, 11451-11454
60. Vishnivetskiy, S.A. et al. (2000) An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation. Journal of Biological Chemistry 275, 41049-41057 (Pubitemid 32054932)
61. Kovoor, A. et al. (1999) Targeted construction of phosphorylation- independent b-arrestin mutants with constitutive activity in cells. Journal of Biological Chemistry 274, 6831-6834
62. Celver, J. et al. (2002) Conservation of the phosphate-sensitive elements in the arrestin family of proteins. Journal of Biological Chemistry 277, 9043-9048 (Pubitemid 34952978)
63. Gray-Keller, M.P. et al. (1997) Arrestin with a single amino acid sustitution quenches light-activated rhodopsin in a phosphorylation-independent fashion. Biochemistry 36, 7058-7063 (Pubitemid 27258120)
64. Pan, L., Gurevich, E.V. and Gurevich, V.V. (2003) The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor. Journal of Biological Chemistry 278, 11623-11632 (Pubitemid 36792724)
65. Song, X. et al. (2009) Enhanced arrestin facilitates recovery and protects rod photoreceptors deficient in rhodopsin phosphorylation. Current Biology 19, 700-705
66. Gurevich, V.V. (1998) The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. Journal of Biological Chemistry 273, 15501-15506
67. Hanson, S.M. et al. (2006) Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proceedings of the National Academy of Sciences of the United States of America 103, 4900-4905
68. Vishnivetskiy, S.A. et al. (2010) The role of arrestin alpha-helix I in receptor binding. Journal of Molecular Biology 395, 42-54
69. Gurevich, V.V. et al. (1997) Agonist-receptorarrestin, an alternative ternary complex with high agonist affinity. Journal of Biological Chemistry 272, 28849-28852 (Pubitemid 27498164)
70. Krasel, C. et al. (2005) Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. Journal of Biological Chemistry 280, 9528-9535 (Pubitemid 40409648)
71. Moore, C.A., Milano, S.K. and Benovic, J.L. (2007) Regulation of receptor trafficking by GRKs and arrestins. Annual Review of Physiology 69, 451-482 (Pubitemid 46457651)
72. Gurevich, V.V. et al. (1994) Visual arrestin binding to rhodopsin: Intramolecular interaction between the basic N-terminus and acidic C-terminus of arrestin may regulate binding selectivity. Journal of Biological Chemistry 269, 8721-8727
73. Puig, J. et al. (1995) Synthetic phosphopeptide from rhodopsin sequence induces retinal arrestin binding to photoactivated unphosphorylated rhodopsin. FEBS Letters 362, 185-188
74. Celver, J. et al. (2001) Threonine 180 is requred for G protein-coupled receptor kinase 3 and b-arrestin mediated desensitization of the m-opioid receptor in Xenopus oocytes. Journal of Biological Chemistry 276, 4894-4900
75. Macey, T.A., Lowe, J.D. and Chavkin, C. (2006) Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. Journal of Biological Chemistry 281, 34515-34524 (Pubitemid 46036659)
76. Gurevich, V.V. et al. (2007) How rod arrestin achieved perfection: regulation of its availability and binding selectivity. In Signal Transduction in the Retina (Fliesler, S.J. and Kisselev, O., eds), pp. 55-88, CRC Press, Boca Raton, FL, USA
77. Baylor, D.A., Lamb, T.D. and Yau, K.W. (1979) Responses of retinal rods to single photons. Journal of Physiology 288, 613-634 (Pubitemid 9146907)
78. Krispel, C.M. et al. (2006) RGS expression rate-limits recovery of rod photo responses. Neuron 51, 409-416 (Pubitemid 44189804)
79. Doan, T. et al. (2006) Multiple phosphorylation sites confer reproducibility of the rod's single-photon responses. Science 313, 530-533 (Pubitemid 44148459)
80. Vishnivetskiy, S.A. et al. (2007) Regulation of arrestin binding by rhodopsin phosphorylation level. Journal of Biological Chemistry 282, 32075-32083 (Pubitemid 350106464)
81. Burns, M.E. et al. (2006) Deactivation of phosphorylated and nonphosphorylated rhodopsin by arrestin splice variants. Journal of Neuroscience 26, 1036-1044 (Pubitemid 43237094)
82. Palczewski, K. et al. (1991) Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin. Journal of Biological Chemistry 266, 18649-18654 (Pubitemid 21908133)
83. Pulvermuller, A. et al. (1997) Functional differences in the interaction of arrestin and its splice variant, p44, with rhodopsin. Biochemistry 36, 9253-9260 (Pubitemid 27329511)
84. Nair, K.S. et al. (2005) Light-dependent redistribution of arrestin in vertebrate rods is an energy-independent process governed by protein-protein interactions. Neuron 46, 555-567 (Pubitemid 40797381)
85. Hanson, S.M. et al. (2007) Each rhodopsin molecule binds its own arrestin. Proceedings of the National Academy of Sciences of the United States of America 104, 3125-3128 (Pubitemid 46364124)
86. Strissel, K.J. et al. (2006) Arrestin translocation is induced at a critical threshold of visual signaling and is superstoichiometric to bleached rhodopsin. Journal of Neuroscience 26, 1146-1153 (Pubitemid 43237047)
87. Penn, R.B. et al. (2001) Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. Journal of Biological Chemistry 276, 32648-32656
88. Gurevich, V.V. and Gurevich, E.V. (2008) GPCR monomers and oligomers: it takes all kinds. Trends in Neurosciences 31, 74-81
89. Gurevich, E.V., Benovic, J.L. and Gurevich, V.V. (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109, 421-436 (Pubitemid 34121995)
90. Gurevich, E.V., Benovic, J.L. and Gurevich, V.V. (2004) Arrestin2 expression selectively increases during neural differentiation. Journal of Neurochemistry 91, 1404-1416 (Pubitemid 39658567)
91. Luo, J., Busillo, J.M. and Benovic, J.L. (2008) M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Molecular Pharmacology 74, 338-347
92. Gurevich, V.V. et al. (1995) Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, b2-adrenergic, and m2 muscarinic cholinergic receptors. Journal of Biological Chemistry 270, 720-731
93. Hanson, S.M. et al. (2007) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. Journal of Molecular Biology 368, 375-387 (Pubitemid 46483495)
94. Hanson, S.M. and Gurevich, V.V. (2006) The differential engagement of arrestin surface charges by the various functional forms of the receptor. Journal of Biological Chemistry 281, 3458-3462 (Pubitemid 43845961)
95. Song, X. et al. (2006) Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm. Journal of Biological Chemistry 281, 21491-21499 (Pubitemid 44115487)
96. Carter, J.M. et al. (2005) Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry. Journal of Molecular Biology 351, 865-878 (Pubitemid 41111902)
97. Barak, L.S. et al. (1997) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. Journal of Biological Chemistry 272, 27497-27500 (Pubitemid 27473532)
98. Miller, A.M. and Dean, D.A. (2009) Tissue-specific and transcription factor-mediated nuclear entry of DNA. Advanced Drug Delivery Reviews 61, 603-613
99. Beck, C. et al. (2004) Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges. Current Gene Therapy 4, 457-467 (Pubitemid 39534759)
100. Sadeghi, H. and Hitt, M.M. (2005) Transcriptionally targeted adenovirus vectors. Current Gene Therapy 5, 411-427 (Pubitemid 41052432)
101. Lundberg, C. et al. (2008) Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Current Gene Therapy 8, 461-473
102. Baum, C. et al. (2006) Retrovirus vectors: toward the plentivirus? Molecular Therapy 13, 1050-1063 (Pubitemid 43779189)
103. Ohguro, H. et al. (1994) Topographic study of arrestin using differential chemical modifications and hydrogen/deuterium exchange. Protein Science, 2428-2434
104. Pulvermuller, A. et al. (2000) Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin. Journal of Biological Chemistry 275, 37679-37685 (Pubitemid 32004881)
105. Dinculescu, A. et al. (2002) Insertional mutagenesis and immunochemical analysis of visual arrestin interaction with rhodopsin. Journal of Biological Chemistry 277, 11703-11708 (Pubitemid 34952723)
106. Vishnivetskiy, S.A. et al. (2004) Mapping the arrestin-receptor interface: structural elements responsible for receptor specificity of arrestin proteins. Journal of Biological Chemistry 279, 1262-1268 (Pubitemid 38082650)
107. Gurevich, V.V. et al. (1993) Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptor. Journal of Biological Chemistry 268, 16879-16882 (Pubitemid 23236907)
108. Gurevich, E.V. and Gurevich, V.V. (2006) Arrestins are ubiquitous regulators of cellular signaling pathways. Genome Biology 7, 236
109. Oakley, R.H. et al. (2000) Differential affinities of visual arrestin, barrestin1, and barrestin2 for G protein-coupled receptors delineate two major classes of receptors. Journal of Biological Chemistry 275, 17201-17210 (Pubitemid 30398969)
110. DeGraff, J.L., Gurevich, V.V. and Benovic, J.L. (2002) The third intracellular loop of alpha2-adrenergic receptors determines subtype specificity of arrestin interaction. Journal of Biological Chemistry 277, 43247-43252 (Pubitemid 35285711)
111. Macey, T.A., Gurevich, V.V. and Neve, K.A. (2004) Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons. Molecular Pharmacology 66, 1635-1642 (Pubitemid 39564791)
112. Dale, L.B. et al. (2001) Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1A in human embryonic kidney 293 cells: agonist-stimulated endocytosis is beta-arrestin1 isoform-specific. Molecular Pharmacology 60, 1243-1253 (Pubitemid 33144895)
113. Mundell, S.J. et al. (2000) Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 39, 12828-12836
114. Ahn, S. et al. (2004) Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. Journal of Biological Chemistry 279, 7807-7811 (Pubitemid 38294665)
115. Gurevich, V.V. and Gurevich, E.V. (2003) The new face of active receptor bound arrestin attracts new partners. Structure 11, 1037-1042 (Pubitemid 37103064)
116. Song, X., Gurevich, E.V. and Gurevich, V.V. (2007) Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites. Journal of Neurochemistry 103, 1053-1062 (Pubitemid 47568740)
117. Song, X. et al. (2009) How does arrestin assemble MAP kinases into a signaling complex? Journal of Biological Chemistry 284, 685-695
118. Hanson, S.M. et al. (2006) Visual arrestin binding to microtubules involves a distinct conformational change. Journal of Biological Chemistry 281, 9765-9772 (Pubitemid 43864695)
119. Wu, N. et al. (2006) Arrestin binding to calmodulin: a direct interaction between two ubiquitous signaling proteins. Journal of Molecular Biology 364, 955-963 (Pubitemid 44765044)
120. Meng, D. et al. (2009) MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization. Journal of Biological Chemistry 284, 11425-11435
121. Gurevich, V.V., Gurevich, E.V. and Cleghorn, W.M. (2008) Arrestins as multi-functional signaling adaptors. Handbook of Experimental Pharmacology 186, 15-37
122. Kim, Y.M. and Benovic, J.L. (2002) Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking. Journal of Biological Chemistry 277, 30760-30768
123. Kang, D.S. et al. (2009) Structure of an arrestin2/clathrin complex reveals a novel clathrin binding domain that modulates receptor trafficking. Journal of Biological Chemistry 284, 29860-29872
124. Baillie, G.S. et al. (2007) Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays. Biochemical Journal 404, 71-80 (Pubitemid 46788086)
125. Luttrell, L.M. et al. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proceedings of the National Academy of Sciences of the United States of America 98, 2449-2454 (Pubitemid 32209502)
126. McDonald, P.H. et al. (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577
127. Miller, W.E. et al. (2001) Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3. Journal of Biological Chemistry 276, 27770-27777
128. Scott, M.G. et al. (2002) Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. Journal of Biological Chemistry 277, 37693-37701
129. Wang, P. et al. (2003) Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. Journal of Biological Chemistry 278, 11648-11653 (Pubitemid 36792727)
130. Miller, W.E. and Lefkowitz, R.J. (2001) Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Current Opinion in Cell Biology 13, 139-145 (Pubitemid 32209213)
131. Li, X. et al. (2009) A scanning peptide array approach uncovers association sites within the JNK/betaarrestin signalling complex. FEBS Letters 583, 3310-3316
132. Schleicher, A., Kuhn, H. and Hofmann, K.P. (1989) Kinetics, binding constant, and activation energy of the 48-kDa protein-rhodopsin complex by extra-metarhodopsin II. Biochemistry 28, 1770-1775 (Pubitemid 19072052)
133. Xiao, K. et al. (2004) Activation-dependent conformational changes in {beta}-arrestin 2. Journal of Biological Chemistry 279, 55744-55753
134. Nobles, K.N. et al. (2007) The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. Journal of Biological Chemistry 282, 21370-21381 (Pubitemid 47099966)
135. Vishnivetskiy, S.A. et al. (2002) Transition of arrestin into the active receptor-binding state requires an extended interdomain hinge. Journal of Biological Chemistry 277, 43961-43967 (Pubitemid 36157820)
136. Bhandari, D. et al. (2007) Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. Journal of Biological Chemistry 282, 36971-36979
137. Gaidarov, I. and Keen, J.H. (1999) Phosphoinositide-AP-2 interactions required for targeting to plasma membrane clathrin-coated pits. Journal of Cell Biology 146, 755-764 (Pubitemid 29408902)
138. Krupnick, J.G. et al. (1997) Modulation of the arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-negative mutants. Journal of Biological Chemistry. 272, 32507-32512 (Pubitemid 28011936)
139. Perry, S.J. et al. (2002) Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298, 834-836 (Pubitemid 35231537)
140. Li, Y. et al. (2009) Regulation of amygdalar PKA by beta-arrestin-2/ phosphodiesterase-4 complex is critical for fear conditioning. Proceedings of the National Academy of Sciences of the United States of America 106, 21918-21923
141. Lin, F.T. et al. (1999) Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases. Journal of Biological Chemistry 274, 15971-15974
142. Shenoy, S.K. et al. (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294, 1307-1313 (Pubitemid 33063090)
143. Shenoy, S.K. et al. (2008) Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. Journal of Biological Chemistry 283, 22166-22176
144. Berthouze, M. et al. (2009) The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO Journal 28, 1684-1696
145. Shenoy, S.K. and Lefkowitz, R.J. (2005) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. Journal of Biological Chemistry 280, 15315-15324 (Pubitemid 40562888)
146. Mosser, V.A. et al. (2008) Differential role of beta-arrestin ubiquitination in agonist-promoted downregulation of M1 vs M2 muscarinic acetylcholine receptors. Journal of Molecular Signaling 3, 20
147. Pals-Rylaarsdam, R. et al. (1997) Internalization of the m2 muscarinic acetylcholine receptor: arrestin-independent and -dependent pathways. Journal of Biological Chemistry 272, 23682-23689 (Pubitemid 27410942)
148. Lee, K.B. et al. (2000) Arrestin binding to the M2 muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. Journal of Biological Chemistry 275, 9284-9289 (Pubitemid 30185149)
149. Shenoy, S.K. et al. (2007) Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. Journal of Biological Chemistry 282, 29549-29546
150. Schubert, C. et al. (1999) Visual arrestin activity may be regulated by self-association. Journal of Biological Chemistry 274, 21186-21190
151. Imamoto, Y. et al. (2003) Concentration-dependent tetramerization of bovine visual arrestin. Biophysical Journal 85, 1186-1195 (Pubitemid 36909679)
152. Hanson, S.M. et al. (2007) Structure and function of the visual arrestin oligomer. EMBO Journal 26, 1726-1736 (Pubitemid 46480940)
153. Granzin, J. et al. (1998) X-ray crystal structure of arrestin from bovine rod outer segments. Nature 391, 918-921 (Pubitemid 28157673)
154. Hanson, S.M. et al. (2008) A model for the solution structure of the rod arrestin tetramer. Structure 16, 924-934 (Pubitemid 351778375)
155. Hanson, S.M. et al. (2008) Opposing effects of inositol hexakisphosphate on rod arrestin and arrestin2 self-association. Biochemistry 47, 1070-1075
156. Milano, S.K. et al. (2006) Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. Journal of Biological Chemistry 281, 9812-9823 (Pubitemid 43864700)
157. Storez, H. et al. (2005) Homo- and hetero-oligomerization of beta-arrestins in living cells. Journal of Biological Chemistry 280, 40210-40215 (Pubitemid 41779158)
158. Kang, J. et al. (2005) A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription.Cell 123, 833-847 (Pubitemid 41721030)
159. Boularan, C. et al. (2007) beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proceedings of the National Academy of Sciences of the United States of America 104, 18061-18066 (Pubitemid 350210820)
160. Xu, T.R. et al. (2008) Mutations of beta-arrestin 2 that limit
161. DeFea, K.A. (2008) Beta-arrestin multimers: does a crowd help or hinder function? Biochemical Journal 413, e1-3
162. Conn, P.J., Christopoulos, A. and Lindsley, C.W. (2009) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nature Reviews Drug Discovery 8, 41-54
163. Kenakin, T.P. (2009) 7TM receptor allostery: putting numbers to shapeshifting proteins. Trends in Pharmacological Sciences 30, 460-469